- Report
- May 2025
- 150 Pages
Global
From €5277EUR$5,950USD£4,577GBP
- Report
- August 2025
- 194 Pages
Global
From €3144EUR$3,545USD£2,727GBP
€3494EUR$3,939USD£3,030GBP
- Report
- August 2025
- 195 Pages
Global
From €3144EUR$3,545USD£2,727GBP
€3494EUR$3,939USD£3,030GBP
- Report
- August 2025
- 187 Pages
Global
From €3144EUR$3,545USD£2,727GBP
€3494EUR$3,939USD£3,030GBP
- Report
- August 2025
Global
From €4346EUR$4,900USD£3,770GBP
- Report
- May 2025
- 183 Pages
Global
From €3991EUR$4,500USD£3,462GBP
- Report
- May 2025
- 99 Pages
Global
From €3500EUR$4,227USD£3,142GBP
- Report
- August 2025
- 188 Pages
Global
From €3144EUR$3,545USD£2,727GBP
€3494EUR$3,939USD£3,030GBP
- Report
- August 2025
- 90 Pages
Global
From €3500EUR$4,227USD£3,142GBP
- Report
- May 2025
- 100 Pages
Global
From €5277EUR$5,950USD£4,577GBP
- Report
- May 2025
- 100 Pages
Global
From €5277EUR$5,950USD£4,577GBP
- Report
- August 2025
- 197 Pages
Global
From €3144EUR$3,545USD£2,727GBP
€3494EUR$3,939USD£3,030GBP
- Report
- August 2025
- 186 Pages
Global
From €3144EUR$3,545USD£2,727GBP
€3494EUR$3,939USD£3,030GBP
- Report
- August 2025
- 192 Pages
Global
From €3144EUR$3,545USD£2,727GBP
€3494EUR$3,939USD£3,030GBP
- Report
- August 2025
- 197 Pages
Global
From €3144EUR$3,545USD£2,727GBP
€3494EUR$3,939USD£3,030GBP
- Report
- August 2025
- 198 Pages
Global
From €3144EUR$3,545USD£2,727GBP
€3494EUR$3,939USD£3,030GBP
- Report
- August 2025
- 184 Pages
Global
From €3144EUR$3,545USD£2,727GBP
€3494EUR$3,939USD£3,030GBP
- Report
- August 2025
- 197 Pages
Global
From €3144EUR$3,545USD£2,727GBP
€3494EUR$3,939USD£3,030GBP
- Report
- August 2025
- 186 Pages
Global
From €3144EUR$3,545USD£2,727GBP
€3494EUR$3,939USD£3,030GBP
- Report
- August 2025
- 182 Pages
Global
From €3144EUR$3,545USD£2,727GBP
€3494EUR$3,939USD£3,030GBP

The Psoriasis Drugs market is a segment of the pharmaceutical industry that focuses on the development and sale of drugs used to treat psoriasis, a chronic skin condition. Psoriasis is characterized by red, scaly patches on the skin, and can cause itching, burning, and pain. Psoriasis drugs are designed to reduce inflammation, reduce the rate of skin cell growth, and reduce the severity of symptoms.
The Psoriasis Drugs market is highly competitive, with many companies offering a variety of treatments. Some of the major players in the market include AbbVie, Amgen, Celgene, Janssen, and Novartis. These companies offer a range of treatments, including topical creams, oral medications, and biologic drugs. Other companies in the market include Sun Pharmaceuticals, Glenmark Pharmaceuticals, and Lupin Pharmaceuticals. Show Less Read more